Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 36
1949 87
1950 82
1951 137
1952 130
1953 119
1954 113
1955 154
1956 150
1957 164
1958 158
1959 140
1960 138
1961 130
1962 125
1963 153
1964 185
1965 202
1966 240
1967 272
1968 305
1969 370
1970 354
1971 454
1972 480
1973 410
1974 517
1975 550
1976 722
1977 840
1978 728
1979 678
1980 985
1981 892
1982 884
1983 813
1984 966
1985 959
1986 873
1987 857
1988 833
1989 869
1990 901
1991 994
1992 947
1993 1262
1994 958
1995 747
1996 764
1997 752
1998 785
1999 798
2000 845
2001 773
2002 806
2003 804
2004 756
2005 785
2006 766
2007 737
2008 818
2009 714
2010 1026
2011 1130
2012 959
2013 767
2014 751
2015 768
2016 660
2017 816
2018 742
2019 758
2020 838
2021 781
2022 650
2023 615
2024 627
2025 397

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44,700 results

Results by year

Filters applied: . Clear all
Page 1
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V, Bossi P; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). Elad S, et al. Cancer. 2020 Oct 1;126(19):4423-4431. doi: 10.1002/cncr.33100. Epub 2020 Jul 28. Cancer. 2020. PMID: 32786044 Free PMC article.
Top advances of the year: Cervical cancer.
Duska LR, Podwika SE, Randall LM. Duska LR, et al. Cancer. 2024 Aug 1;130(15):2571-2576. doi: 10.1002/cncr.35334. Epub 2024 Apr 23. Cancer. 2024. PMID: 38651760 Review.
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer.
Sands JM, Champiat S, Hummel HD, Paulson KG, Borghaei H, Alvarez JB, Carbone DP, Carlisle JW, Choudhury NJ, Clarke JM, Gadgeel SM, Izumi H, Navarro A, Lau SCM, Lammers PE, Huang S, Hamidi A, Mukherjee S, Owonikoko TK. Sands JM, et al. Cancer. 2025 Feb 1;131(3):e35738. doi: 10.1002/cncr.35738. Cancer. 2025. PMID: 39876075 Free PMC article. Review.
Errata.
[No authors listed] [No authors listed] Cancer. 2019 Apr 15;125(8):1387-1388. doi: 10.1002/cncr.31887. Epub 2019 Feb 27. Cancer. 2019. PMID: 30934126 Free article. No abstract available.
Errata.
[No authors listed] [No authors listed] Cancer. 2019 Apr 15;125(8):1387. doi: 10.1002/cncr.32021. Epub 2019 Feb 1. Cancer. 2019. PMID: 30934125 Free article. No abstract available.
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.
Bielamowicz K, Dimitrion P, Abla O, Bomken S, Campbell P, Collin M, Degar B, Diamond EL, Eckstein OS, El-Mallawany N, Fluchel M, Goyal G, Henry MM, Hermiston M, Hogarty M, Jeng M, Jubran R, Lubega J, Kumar A, Ladisch S, McClain KL, Merad M, Mi QS, Parsons DW, Peckham-Gregory E, Picarsic J, Prudowsky ZD, Rollins BJ, Shaw PH, Wistinghausen B, Rodriguez-Galindo C, Allen CE; North American Consortium for Histiocytosis. Bielamowicz K, et al. Cancer. 2024 Jul 15;130(14):2416-2439. doi: 10.1002/cncr.35301. Epub 2024 Apr 30. Cancer. 2024. PMID: 38687639 Free PMC article. Review.
44,700 results
You have reached the last available page of results. Please see the User Guide for more information.